27.09.2011 • News

Celesio Sells Its Joint Venture Stake To Medco Health Solutions

Pharmaceutical and healthcare service provider Celesio and Medco Health Solutions Tuesday said they have mutually agreed to terminate their collaboration on offering services for chronically ill patients effective September 30.

Celesio sells its 50% share in the Medco Celesio joint venture to Medco Health Solutions. The two companies agreed to maintain confidentiality regarding the purchase price and other terms of the agreement.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read